- Home
- AFBI vs GLSI Comparison
AFBI vs GLSI Comparison
Compare AFBI & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- GLSI
- Stock Information
- Founded
- AFBI 1928
- GLSI 2006
- Country
- AFBI United States
- GLSI United States
- Employees
- AFBI N/A
- GLSI N/A
- Industry
- AFBI Major Banks
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- AFBI Finance
- GLSI Health Care
- Exchange
- AFBI Nasdaq
- GLSI Nasdaq
- Market Cap
- AFBI 117.0M
- GLSI 133.4M
- IPO Year
- AFBI N/A
- GLSI 2020
- Fundamental
- Price
- AFBI $18.77
- GLSI $8.90
- Analyst Decision
- AFBI
- GLSI Strong Buy
- Analyst Count
- AFBI 0
- GLSI 1
- Target Price
- AFBI N/A
- GLSI $39.00
- AVG Volume (30 Days)
- AFBI 6.8K
- GLSI 33.7K
- Earning Date
- AFBI 07-25-2025
- GLSI 08-13-2025
- Dividend Yield
- AFBI 8.03%
- GLSI N/A
- EPS Growth
- AFBI N/A
- GLSI N/A
- EPS
- AFBI 0.91
- GLSI N/A
- Revenue
- AFBI $31,043,000.00
- GLSI N/A
- Revenue This Year
- AFBI N/A
- GLSI N/A
- Revenue Next Year
- AFBI N/A
- GLSI N/A
- P/E Ratio
- AFBI $20.21
- GLSI N/A
- Revenue Growth
- AFBI 4.89
- GLSI N/A
- 52 Week Low
- AFBI $17.00
- GLSI $8.06
- 52 Week High
- AFBI $22.50
- GLSI $18.15
- Technical
- Relative Strength Index (RSI)
- AFBI 55.25
- GLSI 35.87
- Support Level
- AFBI $18.20
- GLSI $9.40
- Resistance Level
- AFBI $18.55
- GLSI $9.92
- Average True Range (ATR)
- AFBI 0.16
- GLSI 0.29
- MACD
- AFBI 0.02
- GLSI -0.07
- Stochastic Oscillator
- AFBI 61.54
- GLSI 0.00
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.